Particle.news
Investment Pharmaceuticals Drug Manufacturing Research and Development Economic Development Healthcare Access Trade Policy Government Funding Investment Climate Trade Policy
The agreement establishes three research hubs, including an AI-focused center in London, and aims to deliver 10,000 personalized cancer vaccines by 2030.
